Xiaoling Yuan

3.7k total citations · 1 hit paper
26 papers, 3.2k citations indexed

About

Xiaoling Yuan is a scholar working on Molecular Biology, Infectious Diseases and Biomedical Engineering. According to data from OpenAlex, Xiaoling Yuan has authored 26 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Infectious Diseases and 6 papers in Biomedical Engineering. Recurrent topics in Xiaoling Yuan's work include Genomics, phytochemicals, and oxidative stress (6 papers), Nanoplatforms for cancer theranostics (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Xiaoling Yuan is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (6 papers), Nanoplatforms for cancer theranostics (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Xiaoling Yuan collaborates with scholars based in China, United States and Czechia. Xiaoling Yuan's co-authors include Ah‐Ng Tony Kong, Changjiang Xu, Jian You, Hang Yin, Chunqi Zhu, Lihua Luo, Mengshi Jiang, Yongzhong Du, Guoxiang Shen and Bing Qin and has published in prestigious journals such as Nature Communications, ACS Nano and Biomaterials.

In The Last Decade

Xiaoling Yuan

26 papers receiving 3.1k citations

Hit Papers

Targeting photodynamic and photothermal therapy to the en... 2019 2026 2021 2023 2019 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Yuan China 24 1.7k 1.1k 666 361 317 26 3.2k
Wei Ming Australia 34 1.9k 1.1× 424 0.4× 502 0.8× 195 0.5× 214 0.7× 128 3.8k
Qi Zeng China 26 1.3k 0.7× 404 0.4× 648 1.0× 89 0.2× 246 0.8× 111 2.7k
Jing Qi China 28 829 0.5× 819 0.7× 354 0.5× 249 0.7× 439 1.4× 66 2.6k
Aaron Muth United States 25 1.1k 0.7× 230 0.2× 798 1.2× 429 1.2× 279 0.9× 55 2.6k
Ashim K. Mitra United States 39 1.7k 1.0× 445 0.4× 151 0.2× 300 0.8× 798 2.5× 135 4.8k
Julie L. Eiseman United States 34 2.1k 1.3× 306 0.3× 302 0.5× 263 0.7× 344 1.1× 131 3.5k
Bing Du China 32 1.3k 0.8× 510 0.5× 548 0.8× 113 0.3× 145 0.5× 100 2.8k
Michael J. Kelso Australia 30 1.6k 0.9× 259 0.2× 557 0.8× 257 0.7× 85 0.3× 82 3.2k
Pu Zhang China 38 3.9k 2.3× 881 0.8× 469 0.7× 164 0.5× 74 0.2× 128 5.1k

Countries citing papers authored by Xiaoling Yuan

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Yuan more than expected).

Fields of papers citing papers by Xiaoling Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Yuan. The network helps show where Xiaoling Yuan may publish in the future.

Co-authorship network of co-authors of Xiaoling Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Yuan. A scholar is included among the top collaborators of Xiaoling Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Yuan. Xiaoling Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Bing, Xiaoling Yuan, Mengshi Jiang, et al.. (2020). Targeting DNA to the endoplasmic reticulum efficiently enhances gene delivery and therapy. Nanoscale. 12(35). 18249–18262. 30 indexed citations
2.
Yin, Hang, Xiaoling Yuan, Lihua Luo, et al.. (2020). Appropriate Delivery of the CRISPR/Cas9 System through the Nonlysosomal Route: Application for Therapeutic Gene Editing. Advanced Science. 7(14). 1903381–1903381. 36 indexed citations
3.
Li, Wei, Jie Yang, Lihua Luo, et al.. (2019). Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nature Communications. 10(1). 3349–3349. 939 indexed citations breakdown →
4.
Hu, Tao, Haiyang Yu, Min Lu, et al.. (2019). TLR4 and nucleolin influence cell injury, apoptosis and inflammatory factor expression in respiratory syncytial virus‐infected N2a neuronal cells. Journal of Cellular Biochemistry. 120(9). 16206–16218. 13 indexed citations
5.
Luo, Lihua, Jie Yang, Chunqi Zhu, et al.. (2018). Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors. Journal of Controlled Release. 278. 87–99. 108 indexed citations
6.
Pan, Yushan, Yajun Zhai, Xiaoling Yuan, et al.. (2018). Prevalence, resistance pattern, and molecular characterization of Staphylococcus aureus isolates from healthy animals and sick populations in Henan Province, China. Gut Pathogens. 10(1). 31–31. 24 indexed citations
7.
Yuan, Xiaoling, Tao Hu, Huan Qiu, et al.. (2018). Respiratory syncytial virus prolifically infects N2a neuronal cells, leading to TLR4 and nucleolin protein modulations and RSV F protein co-localization with TLR4 and nucleolin. Journal of Biomedical Science. 25(1). 13–13. 46 indexed citations
8.
Yin, Xiaoyi, Lihua Luo, Wei Li, et al.. (2018). A cabazitaxel liposome for increased solubility, enhanced antitumor effect and reduced systemic toxicity. Asian Journal of Pharmaceutical Sciences. 14(6). 658–667. 23 indexed citations
9.
Yang, Jie, Wei Li, Lihua Luo, et al.. (2018). Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance. Biomaterials. 182. 145–156. 111 indexed citations
10.
Yuan, Xiaoling, Zhenyu Yao, Jie Wu, et al.. (2007). G1 Phase Cell Cycle Arrest Induced by SARS-CoV 3a Protein via the Cyclin D3/pRb Pathway. American Journal of Respiratory Cell and Molecular Biology. 37(1). 9–19. 60 indexed citations
11.
Lin, Wen, Guoxiang Shen, Xiaoling Yuan, et al.. (2006). Regulation of Nrf2 Transactivation Domain Activity by p160 RAC3/SRC3 and Other Nuclear Co-Regulators. BMB Reports. 39(3). 304–310. 33 indexed citations
12.
Yuan, Xiaoling, Changjiang Xu, Zui Pan, et al.. (2006). Butylated hydroxyanisole regulates ARE‐mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells. Molecular Carcinogenesis. 45(11). 841–850. 118 indexed citations
14.
Xu, Changjiang, Mou‐Tuan Huang, Guoxiang Shen, et al.. (2006). Inhibition of 7,12-Dimethylbenz(a)anthracene-Induced Skin Tumorigenesis in C57BL/6 Mice by Sulforaphane Is Mediated by Nuclear Factor E2–Related Factor 2. Cancer Research. 66(16). 8293–8296. 315 indexed citations
16.
Yuan, Xiaoling, Jie Wu, Yajun Shan, et al.. (2005). SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via the cyclin D3/pRb pathway. Virology. 346(1). 74–85. 86 indexed citations
17.
Xu, Changjiang, Guoxiang Shen, Xiaoling Yuan, et al.. (2005). ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis. 27(3). 437–445. 148 indexed citations
18.
Yuan, Xiaoling, Zhenyu Yao, Yajun Shan, et al.. (2005). Nucleolar localization of non-structural protein 3b, a protein specifically encoded by the severe acute respiratory syndrome coronavirus. Virus Research. 114(1-2). 70–79. 38 indexed citations
19.
Yuan, Xiaoling, Jianyong Li, Yajun Shan, et al.. (2005). Subcellular localization and membrane association of SARS-CoV 3a protein. Virus Research. 109(2). 191–202. 62 indexed citations
20.
Yuan, Xiaoling, Yuwen Cong, Jing Hao, et al.. (2004). Regulation of LIP Level and ROS Formation Through Interaction of H-Ferritin with G-CSF Receptor. Journal of Molecular Biology. 339(1). 131–144. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026